Related Experiment Video
Updated: Aug 10, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Truth in clinical research trials involving pharmaceutical sponsorship
1Department of Dermatology, Westmead Hospital, Sydney, NSW. ccommens@mail.usyd.edu.au
Abstract:
Large clinical trials are expensive to mount. Funding comes mainly from pharmaceutical companies seeking information on drug efficacy and adverse events. Patients should be informed of the financial and publication agreements reached between those conducting the trials. This is unlikely to have a significant effect on trial participation and will provide patients with information relevant to informed consent. A small proportion of monies raised from drug trials could be set aside to fund both a trial register site and further studies on adverse drug reactions.
Related Concept Videos
Blind Procedures
Ethics in Research
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blinding
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

